N

NYBC Ventures

4 employees

NYBC Ventures to accelerate innovation in blood-related fields and cellular therapies.

Investor insights

Sectors invested in

Therapeutics3
Biotechnology2
Medical2
Health Care1
Pharmaceutical1

Funding rounds participated in

$24M sweet spot round size

Most of their 3 investments are in rounds between $7M and $24M

Investor type

Venture Capital

Basic info

Industry

hospitals and health care

Date founded

2022

Investments made

S

Star Therapeutics raised $90M on September 5, 2023

Investors: Qatar Investment Authority, Westlake Village BioPartners®, Sofinnova Ventures, Russia technology fund, Redmile Group, Soleus Capital Management, L.P., New Leaf Venture Partners, OrbiMed Advisors, RA Capital Management, L.P. and NYBC Ventures

V

VERALOX Therapeutics raised $24M on June 20, 2023

Investors: Sanofi Ventures, JDRF T1D Fund, Genesys Capital, Pappas Capital and NYBC Ventures

T

Thymmune Therapeutics raised $7M on March 1, 2023

Investors: Pillar VC and NYBC Ventures

FAQ